600% Sales Increase
Report of the Chairman and Chief Executive Final
Positive Preliminary Findings from a Clinical Trial of Arthrem®
25 May 2015
Promisia Integrative Limited, announced today positive and statistically significant preliminary results from a clinical trial of Arthrem®, a dietary supplement for joint support.
The randomised, double-blind, placebo-controlled, 12 week trial was conducted by the Rheumatology Research Unit at the University of Otago in New Zealand and was partially funded by the New Zealand Government through Callaghan Innovation. Preliminary results show that supplementation with Arthrem® (1 capsule twice daily) provided significant benefits for research participants aged 35-75 with hip and knee osteoarthritis.
Publication of Peer-Reviewed Research Paper on Arthrem™
20 January 2015
Mr Malcolm Johnson, Chairman of Promisia Integrative Limited announced today the publication of a peer-reviewed scientific research paper. The paper’s first author is the company’s Principal Scientist Dr Sheena Hunt. The research paper was published by the Journal of Inflammation Research, a recognised and authoritative international journal.